According to the National Health and Medical Research Council - NHMRC clinical trials across Australia are in the following categories:
- treatment trials to test new treatments, new medicines or combinations of medicines; or other new therapies such as surgery, the use of new medical devices or new approaches to surgery
- diagnostic or screening trials to evaluate tests or procedures to diagnose and detect diseases or conditions
- prevention trials to test new ways to prevent disease including medicines, vaccines, vitamins, or changes to diet, lifestyle or behaviour
Clinical trials in Australia need to be efficiently administrated and resourced with qualified healthcare professionals as well as suitable patients.
Shanny Dyer, CEO ARCS Australia talks about a recent summit where the CRO (Contract Research Organization) community was asked on the current state of clinical trials in Australia.
Commentary from:
- Tanya Symons, Director at T Symons Associates
- Daniela Caiazza, Director Clinical Operations ANZ, Novotech CRO
- Adam Stoneley, Research Operations Manager, Icon Cancer Centre
- Gabrielle McKee, Chief Operating Officer, CNS Clinical Network
- Joe Taouk, Senior Director Research and Development, IQVIA
#AustralianHealthJournal
#ClinicalTrials
